Yongwang Hou

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Transcription Factor

Lymph Node Metastasis

Top Venues

International journal of immunopathology and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhicong Yang, Yongwang Hou, Jingqi Li, Dandan Xu, Zhichao Yang, Xinsheng Wang
Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression. International journal of immunopathology and pharmacology 38 (2024)
Zhicong Yang, Yongwang Hou, Jingqi Li, Dandan Xu, Zhichao Yang, Xinsheng Wang
Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression. International journal of immunopathology and pharmacology 38 (2024)
Zhicong Yang, Yongwang Hou, Jingqi Li, Dandan Xu, Zhichao Yang, Xinsheng Wang
Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression. International journal of immunopathology and pharmacology 38 (2024)
Zhicong Yang, Yongwang Hou, Jingqi Li, Dandan Xu, Zhichao Yang, Xinsheng Wang
Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression. International journal of immunopathology and pharmacology 38 (2024)
Yongwang Hou, Baoli Xiang, Zhicong Yang, Jiangmin Liu, Dandan Xu, Lina Geng, Minghua Zhan, Yuhuan Xu, Bin Zhang
Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma. International journal of immunopathology and pharmacology 37 (2023)